Explain it to me like I'm…High-school biology — proper terms explained

The Warren family story

A serialized story following one family living with a hereditary disease across generations, showing how each genetics discovery changed the choices they had.

A fictional family, a real disease. We follow the Warrens across generations, and at each time skip we look at two things: what science had just learned about how the illness is passed on, and how that new knowledge changed the choices the family had. The science is real; the family is invented to make it human.

The Warren family

Seven generations, one inherited illness. The highlighted faces are in the chapter you are reading; pick any face to jump to their chapter.

Eleanor Warrenc. 1850s
- Thomas Warrenc. 1850s
  - Albert Warrenc. 1900
    - Grace Warren1930s–50s
      - Henry Warren1930–1990s
        Margaret Warrenb. 1940s
        Sarah Warrenb. 1960s
        Mia Warrentoday
        Noah Warrentoday
        David Warrenb. 1950s
        Leo Warrentoday
    - Walter Warrenc. 1910s
      - Ruth Warrenb. 1920s
        Clara Warrenb. 1950s
        Ellen Warrenb. 1950s

Chapter 1 · around the 1850s3 min read

The Curse on the Warrens

Generations before the word "gene" existed, the Warrens watched the same illness return again and again, always with the same signs, and reached for the only explanation they had: a family curse.

The changes that came first

Thomas was still a young man when he began to notice the change in his mother. It started so gently that for months he found reasons to ignore it. Eleanor's hands and face would not stay still: her fingers drummed at nothing, small twitches ran across her cheeks and shoulders, and her head made little turns she did not seem to choose.

Her temper shifted as well. A woman who had always been calm grew irritable, then low and tearful, then strangely distant, as if part of her had wandered off. She became clumsy, dropping things and stumbling on level ground. Thomas blamed her nerves, or her age, but a few of the oldest people in the village exchanged looks, because they remembered seeing something like it before.

A decline measured in years

Over years, not weeks, the small movements grew into large ones. Eleanor's limbs jerked and swept in a continuous, restless, almost dance-like motion that eased only when she slept. As it advanced, ordinary acts came apart: her balance failed, walking became dangerous, swallowing grew difficult, and her speech slurred and thinned.

Her mind was pulled down the same slope. She found it harder to plan, to concentrate, to hold the thread of a conversation or the sequence of a familiar chore, and her memory frayed. Nothing about it was sudden. The illness advanced gradually and relentlessly across more than a decade, never reversing, until she needed help with everything. That slowness was part of its terror: the family had to watch, knowing where it led.

A curse, and the page of names

Because no one could name the illness, the village named it for them: a curse on the Warrens, a punishment for some old, imagined wrong. Neighbours grew wary, and the church spoke of affliction. Faced with that, the family did the understandable thing for their time: they kept it secret, married quietly, and hoped it would pass them by.

Inside the fear sat a real pattern, one no one in 1850 could interpret. The illness ran in the bloodline, striking some children of an affected parent and sparing others, surfacing in generation after generation. We now know the cause is inherited, and that each child of an affected parent has a one-in-two chance, but that explanation lay more than a century in the future. What the family did keep was a record: Thomas wrote the names, births, and deaths on the flyleaf of the family Bible. It was an act of memory, not science, yet it became the first version of a document the Warrens would carry, and add to, for the next hundred and fifty years.

Key takeaways

Huntington's disease is a progressive brain disorder that usually begins in mid-adult life and worsens gradually over roughly 10 to 20 years.
Its symptoms fall into three groups: movement problems (especially chorea: involuntary, jerky, dance-like movements), cognitive decline (slowed thinking, poor planning and memory), and psychiatric or behavioural changes (irritability, depression, personality change).
The "dance-like" movements are called chorea, from the Greek word for dance, which is why the illness was once known as Huntington's chorea.
The dominant inheritance pattern (each child of an affected parent has a 50% chance) was visible in families like this one but had no explanation in the 1850s.
Before genetics, inherited illness was often blamed on curses or moral failing, so families frequently hid it.

What was discovered

No mechanism at all. The symptoms were plain to see, but inheritance was explained through folklore, curses, and superstition rather than biology.

What changed for the family

None. Choices were limited to secrecy, quiet marriages, and decisions driven by fear and superstition.

Chapter 2 · around 19004 min read

A Pattern in the Family Bible

As Mendel's work is rediscovered, a country doctor spots the pattern in the Warren family and sketches the first family tree, giving their fear a shape for the first time.

The doctor with the new ideas

By the time Albert was grown and thinking about marrying, his grandmother Eleanor was long dead, and the family still had no word for what had taken her. What they had instead was dread, and a question Albert could not shake: if he married and had children, was he handing the curse to them?

The answer, or the beginning of one, arrived with the doctor. He was a country physician who read widely, and he had been following something new. In 1900, scientists had rediscovered the forgotten work of a monk named Gregor Mendel, who decades earlier had worked out simple rules for how traits pass from parents to offspring. The newspapers were full of it: a new science of heredity. Albert did not follow the details, but one idea reached him: the way an illness travelled through a family might obey a pattern you could actually work out.

The first family tree

The doctor asked to see the family Bible. On its flyleaf, in three kinds of handwriting, were the names Thomas had begun to keep: births, marriages, and deaths, going back to Eleanor. The doctor read them slowly, then asked which of them had fallen ill, and at what age. As Albert answered, the doctor began to draw.

He sketched the family as a tree, a line of parents and children, marking each person who had suffered the illness. When he finished, the pattern was impossible to miss: the illness appeared in every generation, and only in the children of someone who had already had it. This, the doctor explained, was what the new science would call a dominant trait. A person needs only one copy of the hidden factor to fall ill, so an affected parent passes it to each child with a one-in-two chance, like a coin toss repeated for every birth. He even had a name for the illness now, one a doctor had published in America a generation earlier: Huntington's chorea, chorea meaning dance, for the restless movements.

A name, and its price

For the first time, the family's fear had a shape. Albert could put a number to the question that had frightened him: not certainty, but a known risk, one chance in two for each child. That was its own kind of gift. A pattern you can name is a pattern you can talk about, weigh, and plan around, in a way a curse never allowed.

But the same knowledge that could steady the family could just as easily be turned against them, and the times made that danger real. These were the years when many people took the new science of heredity and twisted it into eugenics: the idea that society should discourage or even prevent "unfit" families from having children. A named hereditary illness could become a label used against you. So Albert's new clarity came wrapped in a new danger, and the old instinct to hide did not simply disappear. Before the doctor left, he folded his drawing and tucked it inside the Bible, next to the names. The family's oldest record and its first piece of science now sat on the same page.

Key takeaways

Gregor Mendel's laws of inheritance, presented in 1865 and published in 1866, were rediscovered around 1900 and gave heredity its first modern rules.
Huntington's is a dominant trait: one copy of the faulty factor causes the illness, so each child of an affected parent has a 50% chance.
A pedigree (a family tree marking who is affected) makes a dominant pattern visible: it appears in every generation and does not skip.
Huntington's chorea had been described in the United States in 1872; after 1900 it was understood as a Mendelian dominant condition.
This was the eugenics era, when hereditary illness could be used to stigmatise families, so naming the condition carried real social risk.

What was discovered

Around 1900 Mendel's laws of inheritance were rediscovered, and a country doctor used them to spot the pattern, name the 50% risk, and sketch the family's first pedigree.

What changed for the family

Naming the 50% pattern gave the family a shared language for marriage and children, but the eugenics era attached real stigma and danger to it.

Chapter 3 · 1930s to 1950s4 min read

Genes Made Real

Grace grows up wanting to know what the illness really is, and lives through the era when genes stop being an abstract rule and become physical: chromosomes, then DNA.

What is it, really?

Grace grew up with the pedigree the doctor had drawn, folded into the family Bible beside the names. She knew the pattern by heart: the illness came in every generation, and each child of an affected parent had a one-in-two chance. But knowing the odds was not the same as understanding, and Grace wanted to understand. What was the thing that passed down? Where did it live? What actually happened inside a person to make the movements start?

Nobody around her could say. So she listened. Through the 1930s and 1940s, the radio and the popular magazines were full of a fast-moving new science, and Grace followed it the way other people followed the news. Slowly, from a hundred small reports, an answer began to assemble: the illness was not a curse and not a punishment. It was something physical, carried in the body, and science was closing in on exactly what.

Genes become things you can touch

First came the location. Scientists had shown that the hereditary factors Mendel described were not floating ideas but sat on chromosomes, the thread-like structures inside every cell, passed from parents to children when cells divide. The family's "factor" had an address.

Then came the substance. For a long time people had assumed the material of heredity must be protein, but experiments in the 1940s and early 1950s pointed instead to DNA, a molecule in the chromosomes, as the thing that actually carried the instructions. And in 1953, two scientists, Watson and Crick, using the X-ray work of Rosalind Franklin and others, described DNA's shape: a double helix, two strands twisted together, built so that it could be copied and passed on. For Grace, this was the answer she had wanted. The curse had a chemistry.

A molecule, not a sin

The change was not in Grace's odds. Her risk was exactly what the doctor had told Albert: one in two, unchanged by any of this. What changed was the meaning. A family curse invites shame; a molecule does not. Understanding that the illness was a physical thing, not a moral stain, loosened something the Warrens had carried for generations, even though it fixed nothing about the danger itself.

It also opened a small, practical door. In these years the first heredity clinics appeared, and in 1947 the phrase "genetic counselling" was coined for the work of helping families understand their risk. For the first time, someone could sit with Grace and talk through her one-in-two chance as a probability, not a doom. That help was still imperfect, and still tangled up with the eugenic thinking of the age, but it was the start of something the family would rely on later. Grace kept a magazine clipping about the double helix folded in the Bible, next to the pedigree: the newest picture of the illness, filed with the oldest.

Key takeaways

By this era, genes were known to sit on chromosomes and to be made of DNA, not protein as once assumed.
Watson and Crick described DNA's double-helix structure in 1953, using X-ray work by Rosalind Franklin and others.
None of this changed Huntington's inheritance: it stayed autosomal dominant, 50% per child.
The term "genetic counselling" was coined in 1947, and the first heredity clinics let families discuss risk as a probability.
Early counselling was still entangled with the eugenics of the time; the non-directive model came later.

What was discovered

Across the 1930s to 1950s, genes were shown to sit on chromosomes and to be made of DNA, whose double-helix structure was described in 1953. Grace pieces it together from radio and popular-science magazines.

What changed for the family

The illness could be understood as physical, easing some of the shame, and the earliest genetic counselling let the family discuss risk as a probability.

Chapter 4 · 1960s to 1970s4 min read

The Counsellor's Office

As genetic counselling matures, a young Henry sits in a counsellor's office to weigh the odds before starting a family, in an era that could explain risk but not yet test for it.

The appointment

By the time Henry was grown and married to Margaret, the shape of his life was clear to him. He had watched the illness in the family for years, and now he was thinking about children of his own. He wanted to make that choice with his eyes open, so he and Margaret did something none of his ancestors could: they made an appointment with a genetic counsellor.

The counsellor's office was a new kind of place. Through the 1960s and 1970s, genetic counselling had grown into a real profession, with its own training, built on a firm rule: the counsellor's job was to help a family understand its situation, not to tell them what to do. Henry brought the old pedigree from the family Bible. The counsellor spread it out, added Henry and Margaret to the bottom, and began, gently, to talk about numbers.

The odds, done honestly

The rule Henry already half-knew: Huntington's is dominant, so each child of an affected parent has a one-in-two chance, and his mother had by now developed the illness. But the counsellor was careful, because Henry's own situation had a twist. Henry was not ill. He might carry the faulty factor, or he might not, and in the 1960s there was no way to look and see.

That uncertainty changed the maths for his children. If Henry carried it, each child would be at one in two. But there was only a one-in-two chance he carried it at all. Put together, the risk to each of Henry's children was about half of a half: roughly one in four. The counsellor explained, too, that a newer test called amniocentesis, which draws a little fluid from around a developing baby, could now check for certain conditions during pregnancy. But not for this one: with no way yet to spot Huntington's in the DNA, amniocentesis had nothing to look for. The family still had only the odds.

Deciding with only the odds

What the counsellor would not do was decide for them. She laid out the numbers, the uncertainty, and the options as clearly as she could, and then she left the choice where it belonged: with Henry and Margaret. That was the whole point of the new approach. A generation earlier, the same conversation might have carried a push toward not having children at all, in the name of eugenics. This one did not.

So Henry and Margaret decided the way people do: with incomplete information and open eyes. They chose to have children, holding the one-in-four figure and the hope that Henry had drawn the lucky half. It was not a scientific breakthrough that helped them, but a human one: honest counsel, freely given, with the decision left to the people who had to live it. Henry folded the updated pedigree back into the Bible, his own name now on it, next to his mother's.

Key takeaways

Non-directive genetic counselling helps people make their own decisions rather than telling them what to do; it matured into a profession in the 1960s to 1970s.
Huntington's recurrence risk is 50% for each child of an affected parent.
Because Henry was untested and unaffected, each of his children's risk was about 1 in 4 (half of his own 50% chance of carrying it).
Amniocentesis (sampling fluid around the fetus) existed for some conditions but could not detect Huntington's, which had no known gene or marker yet.

What was discovered

Non-directive genetic counselling matured into a profession in the 1960s to 1970s, and prenatal tests like amniocentesis appeared for some conditions (though not for Huntington's). Henry learns it all at a clinic appointment.

What changed for the family

Formal, non-directive recurrence-risk counselling supported informed reproductive decisions, even though no test for Huntington's existed yet.

Chapter 5 · 1986 to 19936 min read

The Letter That Offered an Answer

For the first time in the family's history, the question that had haunted every Warren, "is it coming for me?", had a possible answer. The hard part was deciding whether they wanted to hear it.

The letter, and why they wanted the healthy relatives too

The letter came on university stationery, addressed to Margaret. A research team was studying families like theirs, families where the illness that had taken Henry's mother, and her father before her, surfaced in every generation. What they wanted was blood: from relatives who were sick and relatives who were well, from as many branches as would agree.

Sarah didn't understand, at first, why they'd want samples from the healthy ones. The counsellor explained it the way you'd explain a card trick you're about to see through. The scientists couldn't study this illness the usual way. Normally you start from the damaged part of the body and work backward to the cause, but Huntington's gave them no such thread to pull. So they were trying something sideways. If they collected DNA from enough relatives, they could hunt for a stretch of it that always travelled with the disease: present in the Warrens who fell ill, absent in those who stayed well. They didn't need to know what the gene did, only where in the genome it rode along. That was why they needed the well relatives too: as the "absent" half of the pattern, the control that made the signal readable.

The magazine article: how the hunt actually worked

They gave their blood (Henry, Margaret, Sarah, David, two cousins) and for years heard nothing.

It was David, of all of them, who ended up understanding it best, and he found out from a magazine. Months after they'd given their samples, he was in a waiting room and picked up a science magazine with a cover story on the disease hunt. He read it twice. A scientist named Nancy Wexler, whose own mother had died of Huntington's, had spent years travelling to a cluster of villages on the shore of a lake in Venezuela, where an enormous extended family (thousands of people, all descended from shared ancestors) carried the illness. That was the key the article kept circling back to: you needed a huge family, enough relatives across enough generations that a pattern could rise above chance. From that community's blood, a lab had, in 1983, found a marker on chromosome 4 that shadowed the disease down the generations. A genetic marker is not the gene and does not cause anything; it is simply a spot in the DNA whose location is already known and that comes in recognisably different versions from person to person. Because this particular marker sat so close to the illness gene on the chromosome, the two were almost always inherited as a pair, so following the easy-to-read marker was a way to track the gene no one could yet see. The article called it a landmark: the first time anyone had located a disease gene purely by its address in the genome, with no idea yet what the gene actually made. David sat there realising that his own small vial of blood had gone into something exactly like that.

But the article was careful, and so was he. What they'd found in 1983 was a signpost, not the house. A predictive test built on that marker existed, but it needed DNA from several relatives, including someone already affected, and it still answered in probabilities, not certainties. The house itself was still being searched for.

The gene, and a test that needed only one tube of blood

Then, in 1993, the counsellor asked them all to come in. The gene had been found, the thing itself now, not the signpost, she told them.

And she'd clearly explained it many times, because she reached for an everyday picture. Imagine a word in the gene that's supposed to be said once, cleanly, but instead it stutters, CAG-CAG-CAG, too many times in a row. A usual copy repeats it a modest number of times. Once it repeats about 36 times or more it tips into disease, and (this was the part that made Sarah go quiet) the longer the stutter, the earlier in life the illness tends to arrive. Because they now knew the exact change, the doctor said, the test no longer needed the whole family lined up. It needed one tube of blood. From Sarah's arm alone, they could tell her whether she carried what had taken her grandmother, years, probably decades, before her hands or her walk would ever betray it.

Same knowledge, opposite choices

Sarah was eleven weeks pregnant. She had not told David yet.

They sat with the same information and stood up with opposite answers. David didn't want it. "If I test and it's bad, I've lost every ordinary day between now and when I'd have found out anyway. And if it's good, I'm not sure I'd let myself believe it." He chose to live, as he put it, "in the fifty-fifty": the plain arithmetic of a dominant illness, where every child of an affected parent has a one-in-two chance, the same odds his ancestors had lived under without ever having a name for them. Science had not moved those odds an inch. It had only changed what a person could find out, and David decided he would rather not.

For Sarah the not-knowing had curdled into something sharper, because she wasn't only asking about herself anymore. The clinic wouldn't hand her a result that same afternoon. There were counselling sessions first, built deliberately so no one learned a thing this size in one overwhelming sitting, and the counsellor mentioned, almost gently, that most people who could take this test choose not to. Knowing was possible now; wanting to know was still a different decision, and it was hers alone. She learned there were further options her grandmother could never have imagined, a way to test a pregnancy, and newer approaches that could keep the change from being passed on at all, and also a new kind of exposure, because a result that might reassure her could just as easily be turned against her by an insurer. Privacy, suddenly, was a genetic question.

When the result finally came, Margaret opened the family Bible to the page of names, births and deaths in three kinds of handwriting, and tucked beside them the chart the counsellor had drawn: the same family, the same generations, redrawn in squares and circles. The oldest record the Warrens kept and the newest science had, without anyone quite planning it, become the same document.

Key takeaways

Huntington's is inherited in an autosomal dominant pattern: one affected parent gives each child a 50% risk.
The gene was located by linkage in 1983, the first disease gene mapped this way, and identified in 1993 as an expanded CAG repeat.
Linkage mapping finds a gene from its inheritance pattern alone, which is why studies needed DNA from healthy relatives and very large families.
Longer CAG expansions tend to mean earlier onset.
A predictive test can reveal status years before symptoms, but most at-risk people choose not to take it.

What was discovered

The gene was located by linkage in 1983 and identified in 1993 as an expanded CAG repeat. The family learns through a research-study letter, a magazine article on the Venezuela gene hunt, and their genetic counsellor.

What changed for the family

Predictive (presymptomatic) testing became possible, along with prenatal testing, forcing the deeply personal choice of whether to know at all.

Chapter 6 · 1990s to 2010s5 min read

Choosing the Next Generation

With the gene identified, Sarah's family meets a new set of options: IVF with embryo testing, prenatal and exclusion testing, and the new question of who is allowed to see your genetic results.

Options her father never had

Sarah knew what she carried. The test she had taken while pregnant with Mia had told her: she had the expansion, and one day the illness would come for her as it had for her father, Henry. That knowledge was heavy, but it also placed her, for the first time in the family's history, in front of real choices. When she and her husband began to think about another child, they did not go to a counsellor to be told the odds and sent home. They went to a fertility clinic.

Because the gene itself was now known, the doctors could do something no Warren had ever been offered: act before a child was even born, and even before a pregnancy began. The counsellor from her father's day could only describe the risk. This clinic could change what happened to it.

Choosing before birth

The doctor laid out a range of options, each a different answer to the same question: how do you keep the expansion from reaching the next child?

The oldest route was prenatal testing. Once a pregnancy was under way, a sample of the developing fetus's cells could be taken and tested directly for the expansion, giving a clear answer but leaving only the hardest choice if the answer was bad. The newer route was preimplantation genetic diagnosis, or PGD. With IVF, several embryos are created in the lab; a single cell is taken from each and tested for the expansion; and only embryos without it are placed in the womb. A child could be conceived already free of what had haunted the family for two centuries. Because Sarah already knew she carried the expansion, she could test her embryos for it directly.

There was even an option for a relative who did not want to know their own fate, like her brother David. In exclusion testing, doctors do not test the parent at all. They check whether an embryo inherited the stretch of chromosome that came from the affected grandparent, and set aside the ones that did. A couple could avoid passing on the risk while the at-risk parent kept their own right not to know.

The internet knows too

While Sarah weighed embryos, Mia was growing up, and the world she was growing into had its own new twist. By the 2000s, a person could order a DNA test over the internet, spit into a tube, mail it off, and receive pages about their ancestry and health from a company, no doctor required. For most families that was a curiosity. For a family like the Warrens, it was a landmine: a casual kit could hand a teenager a life-defining answer she was far too young to be given, one that doctors agree should wait for adulthood and careful counselling.

With results flying around so easily, a new question sharpened: who is allowed to see them? A genetic result that might reassure Sarah could also, in the wrong hands, be used to deny her insurance or a job. Laws began to catch up: in the United States, the Genetic Information Nondiscrimination Act of 2008 banned the use of genetic information in health insurance and employment. But the protection had holes; it did not cover life insurance or long-term-care cover, exactly the kinds a family with Huntington's most needs. Privacy was now part of the illness. When the family's records finally moved from the Bible's flyleaf onto a computer, the pedigree Thomas had started by candlelight had become data: powerful, portable, and newly worth protecting.

Key takeaways

Huntington's remains autosomal dominant: 50% per child of a carrier.
Prenatal testing checks a fetus directly; PGD with IVF tests embryos and transfers only those without the expansion.
Exclusion testing avoids transmission using markers from the affected grandparent, without revealing the at-risk parent's status.
Predictive testing of children is not recommended; it should wait for informed, adult consent.
Direct-to-consumer kits and privacy law (US GINA, 2008) arrived, but GINA does not cover life or long-term-care insurance.

What was discovered

Knowing the gene enabled prenatal testing, PGD with IVF, and exclusion testing, while direct-to-consumer kits and genetic-privacy law arrived. The family meets it through a fertility clinic and the internet.

What changed for the family

The family could have an unaffected child via PGD (or exclusion testing without learning a parent's status), and faced new choices about disclosure and privacy.

Chapter 7 · 2010s to the future5 min read

Rewriting the Sentence

As a young adult, Mia follows news of gene-silencing trials for Huntington's and gene-editing tools like CRISPR: cautious hope, and hard new questions.

News of a different kind

Mia grew up knowing the whole story. She had seen the family record, no longer a Bible flyleaf but a file on a screen, that ran from Eleanor in the 1850s all the way down to her own name. She knew the odds by heart: as the child of a mother who carried the expansion, she had a one-in-two chance of carrying it too. What her ancestors did not have, and what Mia did, was a steady stream of news suggesting that the illness might one day be not just predicted, but treated.

Much of it started with a tool. In 2012, scientists described CRISPR, a way to find a chosen spot in DNA and cut or change it, far more cheaply and easily than anything before. Suddenly the headlines were full of the idea of fixing genes at their source. CRISPR was not itself a Huntington's cure, but it changed the mood of the whole field, and it made a question real that had never been practical before: not just how do you live with a faulty gene, but could you switch it off?

Turning the gene down

The most promising work for Huntington's did not try to rewrite the gene at all. It tried to quiet it. The expanded gene makes a harmful version of a protein called huntingtin, and the more of that faulty protein builds up in the brain, the more damage it does. So researchers designed drugs to step in between the gene and the protein, and lower how much of the harmful version gets made. The goal was simple to say and hard to do: less bad protein, slower disease.

An early trial in 2019 was genuinely exciting: one such drug did lower the huntingtin protein in patients. But the story since has been a lesson in honest hope. A larger trial was stopped in 2021 because the drug was not helping people as expected, and might even have been harmful at high doses. Researchers went back, adjusted the doses and the patients they focused on, and kept going. As Mia read it, the message was careful: this was real science moving in the right direction, not a finished cure. For the first time, though, the family's illness had something aimed squarely at its root.

Hope, and where to draw the line

With editing tools in the world, a harder question arrived: should you change genes in a way that passes to future children? Treating a person who already has the illness, working only on their own body cells, is one thing. Editing an embryo, so the change is written into every future generation, is another, and in 2018 a scientist who did exactly that, editing babies' genes, was condemned around the world, then jailed in 2019. Most countries ban it. And for Huntington's it is doubly unnecessary, because the family already had a way to avoid passing it on: the embryo testing Sarah's generation used, no editing required.

The deeper change for Mia was quieter. For most of the family's history, David's logic had held: why find out, when you can do nothing about it? But if a treatment ever works, and works best when started early, then knowing your status early could actually matter. When a clinical-trial invitation arrived in her inbox, asking people at risk to help study the illness, Mia felt the old question shift under her feet. She was the first Warren to face her fifty-fifty not as a fixed sentence, but as something science was, however slowly, learning to rewrite. That is where the family's two hundred years leave her: not cured, not certain, but for the first time, hopeful with her eyes open.

Key takeaways

Huntington's remains autosomal dominant: 50% per child of a carrier.
CRISPR-Cas9 (2012) made gene editing far easier and cheaper, and reshaped the whole field.
The main Huntington's approach is gene silencing: lowering the harmful huntingtin protein, not editing the gene.
An early trial lowered the protein, but a large trial was stopped in 2021; gene-silencing therapies remain investigational, not cures.
Germline editing (heritable, e.g. in embryos) is banned in most countries; the "CRISPR babies" scientist was condemned in 2018 and jailed in 2019.

What was discovered

CRISPR (2012) transformed gene editing, and Huntington's research focused on "gene silencing", lowering the harmful huntingtin protein. Early trials lowered the protein but a large trial was stopped in 2021, so hope stays cautious. Mia learns it from the news and a trial invitation.

What changed for the family

Emerging therapies aim to slow or treat the illness itself, offering cautious hope, and raising new ethical questions about editing genes that pass to future generations.

The book · Coming soon

From Curse to Code

The Warren saga continues in a full literary book: seven narrative chapters paired with science interludes that explain the genetics behind each era. Same family, same inherited illness — told at greater depth than the web story, with room to breathe between discovery and choice.

7 chapters + 7 interludes · 1850s to the future

Chapter 5 · 1986 to 19936 min read

The Letter That Offered an Answer

For the first time in the family's history, the question that had haunted every Warren, "is it coming for me?", had a possible answer. The hard part was deciding whether they wanted to hear it.

The letter, and why they wanted the healthy relatives too

The magazine article: how the hunt actually worked

They gave their blood (Henry, Margaret, Sarah, David, two cousins) and for years heard nothing.

The gene, and a test that needed only one tube of blood

Then, in 1993, the counsellor asked them all to come in. The gene had been found, the thing itself now, not the signpost, she told them.

Same knowledge, opposite choices

Sarah was eleven weeks pregnant. She had not told David yet.